Your search returned 4 results.

Results
	1.	Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. [electronic resource] by Krieg, Arthur M Efler, Susan M Wittpoth, Michael Al Adhami, Mohammed J Davis, Heather L Producer: 20050418 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers. [electronic resource] by Cooper, Curtis L Ahluwalia, Navneet K Efler, Susan M Vollmer, Jörg Krieg, Arthur M Davis, Heather L Producer: 20110714 In: Journal of immune based therapies and vaccines vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist. [electronic resource] by Vicari, Alain P Schmalbach, Tess Lekstrom-Himes, Julie Morris, Mary Louise Al-Adhami, Mohammed J Laframboise, Chantal Leese, Philip Krieg, Arthur M Efler, Susan M Davis, Heather L Producer: 20071019 In: Antiviral therapy vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	4.	Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus. [electronic resource] by McHutchison, John G Bacon, Bruce R Gordon, Stuart C Lawitz, Eric Shiffman, Mitchell Afdhal, Nezam H Jacobson, Ira M Muir, Andrew Al-Adhami, Mohammed Morris, Mary L Lekstrom-Himes, Julie A Efler, Susan M Davis, Heather L Producer: 20071218 In: Hepatology (Baltimore, Md.) vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)